Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02905149|
Recruitment Status : Completed
First Posted : September 19, 2016
Last Update Posted : August 2, 2017
|Condition or disease||Intervention/treatment||Phase|
|Surgery Breast Reconstruction||Procedure: Serrato Procedure: Control||Phase 4|
Regional analgesia techniques have shown to have benefits over conventional analgesia. The lower opioids analgesics requirements decrease side effects associated with the use of this type of medication. It is also increasingly established scientific evidence that reducing opioids administration may play a role in prognosis of cancer patients given the immunosuppressive effect of these drugs.
In patients undergoing oncologic/reconstructive breast surgery paravertebral block has been traditionally performed, however the paravertebral space lacks a clear anatomical barrier from the spinal cord so the drugs administered can diffuse to the intervertebral foramen causing deeper levels of blocks (epidural or spinal blocks) and injections at the paravertebral level are associated with serious complications both neurological and respiratory (meningitis, spinal hematomas abscesses, pneumothorax, respiratory failure. This has led to the development of less invasive technique with an improved safety profile.
The serratus plane block falls within the framework of these newly developed techniques and the present study aims to assess its role in the management of the patient undergoing cancer / reconstructive surgery.
Considering a decrease in postoperative morphine consumption of 40% and the average consumption of opioid after breast surgery under general anesthesia is 15 milligrams ( standard deviation 8 mg ) investigators calculated that with an alpha error 5% power 80 % 56 patients (28 per group) were required to achieve a significant result. In anticipation of possible loss of sample, 60 patients were recruited . Analysis will be performed by intention to treat.
Quantitative variables (opioid consumption, pain estimated by VAS scale) will be analyzed using mixed linear model adding a random variable for interindividual variability for pain threshold. If the data do not meet the criteria of normality the Mann-Whitney U test will be used. If the groups differ in preoperative variables. Investigators will make a multivariable analysis adjusting for these variables. The need for rescue analgesia over time is analyzed by Kaplan-Meier curve where the terminal state is the administration of the first dose of opioid postoperatively. The difference side effects (nausea, pruritus, apnea, urinary retention, ileus ) and complications IPO questionnaire and analyzed by chi-square test and Fisher exact test. Scheffe correction will be applied for multiple comparison. Missing data are excluded from analysis.
The study has planned data monitoring and auditing by the IIS la Fe according to AEMPS guidelines. Registries will be obtained from electronic medical records available for double check procedures.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Supportive Care|
|Official Title:||Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast|
|Actual Study Start Date :||August 2, 2016|
|Actual Primary Completion Date :||June 8, 2017|
|Actual Study Completion Date :||July 8, 2017|
Standard anesthesia+serratus plane block.
Serratus plane block.
Placebo Comparator: Control
- Total opioid usage [ Time Frame: First 24 hours after surgery ]Total opioid usage first 24 hours (intra and postoperative) (in morphine mgs, fentanyl/morphine conversion = 10 mcgs/1mg)
- Pain at rest and coughing [ Time Frame: First 24 hours after surgery ]Pain at rest and coughing at 1h, 3h, 6h, 12h, 24h postoperative (Visual analogue scale 0-10).
- Time to first opioid administration on the ward [ Time Frame: First 24 hours after surgery ]Time to first opioid administration on the ward
- Opioid related complications [ Time Frame: First 24 hours after surgery ](nausea/vomit, apnea, urinary retention, ileus)
- Gender [ Time Frame: First 24 hours after surgery ]Gender
- Age [ Time Frame: First 24 hours after surgery ]Age
- Weight [ Time Frame: First 24 hours after surgery ]Weight
- Height [ Time Frame: First 24 hours after surgery ]Height
- Body mass index [ Time Frame: First 24 hours after surgery ]Body mass index
- American Society of Anesthesiologist surgical risk scale (from I to V) [ Time Frame: First 24 hours after surgery ]ASA ≥ IV
- Surgery duration (in minutes) [ Time Frame: First 24 hours after surgery ]Surgery duration (in minutes)
- Surgical procedure [ Time Frame: First 24 hours after surgery ](tumorectomy + sentinel lymph biopsy, simple mastectomy, radical mastectomy, axillary lymph exeresis)
- Internation Pain [ Time Frame: First 24 hours after surgery ]Internation Pain Outcome questionnaire http://pain-out.med.uni-jena.de/.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02905149
|Hospital de Manises|
|Manises, Valencia, Spain, 46940|
|Principal Investigator:||Guido Mazzinari||Instituto de Investigación Sanitaria La Fe|